Potential Utility of Contrast-Enhanced Ultrasound in the Preoperative Evaluation of Primary Hyperparathyroidism.
Contrast Media
Female
Humans
Hyperparathyroidism, Primary
/ diagnostic imaging
Image Enhancement
/ methods
Male
Middle Aged
Organotechnetium Compounds
Parathyroid Glands
/ diagnostic imaging
Preoperative Care
/ methods
Prospective Studies
Radiopharmaceuticals
Sensitivity and Specificity
Tomography, Emission-Computed, Single-Photon
Ultrasonography
/ methods
contrast-enhanced ultrasound
high-resolution ultrasound
primary hyperparathyroidism
single-photon emission computed tomography
technetium Tc 99m methoxyisobutylisonitrile scintigraphy
Journal
Journal of ultrasound in medicine : official journal of the American Institute of Ultrasound in Medicine
ISSN: 1550-9613
Titre abrégé: J Ultrasound Med
Pays: England
ID NLM: 8211547
Informations de publication
Date de publication:
Oct 2019
Oct 2019
Historique:
received:
17
10
2018
revised:
18
12
2018
accepted:
30
12
2018
pubmed:
30
1
2019
medline:
10
3
2020
entrez:
30
1
2019
Statut:
ppublish
Résumé
We aimed to compare the effectiveness of contrast-enhanced ultrasound (CEUS), technetium Tc 99m methoxyisobutylisonitrile ( Twenty-nine consecutive patients with pHPT were prospectively enrolled and underwent preoperative imaging with In the 29 patients (22 female and 7 male), a total of 31 parathyroid adenomas were detected: single lesions in 27 patients and a double lesion in 2 patients. Contrast-enhanced US revealed sensitivity of 66.7% (95% confidence interval [CI], 46%-82.7%) for detection of single adenomas in comparison with 77.8 % (95% CI, 57.3%-90.6) for In our study, CEUS facilitated the detection and diagnosis of double adenomas compared with high-resolution US and
Substances chimiques
Contrast Media
0
Organotechnetium Compounds
0
Radiopharmaceuticals
0
technetium 99m methoxyisobutylisonitrile
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
2565-2571Informations de copyright
© 2019 by the American Institute of Ultrasound in Medicine.
Références
Heath H III, Hodgson SF, Kennedy MA. Primary hyperparathyroidism: incidence, morbidity and potential economic impact in a community. N Engl J Med 1980; 302:189-193.
Wermers RA, Khosla S, Atkinson EJ, et al. Incidence of primary hyperparathyroidism in Rochester, Minnesota, 1993-2001: an update on the changing epidemiology of the disease. J Bone Miner Res 2006; 21:171-177.
Kobylecka M, Płazińska MT, Chudziński W, et al. Comparison of scintigraphy and ultrasound imaging in patients with primary, secondary and tertiary hyperparathyroidism: own experience. J Ultrason 2017; 17:17-22.
Bhansali A, Masoodi SR, Bhadada S, Mittal BR, Behra A, Singh P. Ultrasonography in detection of single and multiple abnormal parathyroid glands in primary hyperparathyroidism: comparison with radionuclide scintigraphy and surgery. Clin Endocrinol (Oxf) 2006; 65:340-345.
Krausz Y, Lebensart PD, Klein M, et al. Preoperative localization of parathyroid adenoma in patients with concomitant thyroid nodular disease. World J Surg 2000; 24:1573-1578.
Barbaros U, Erbil Y, Salmashoğlu A, et al. The characteristics of concomitant thyroid nodules cause false-positive ultrasonography results in primary hyperparathyroidism. Am J Otolaryngol 2009; 30:239-243.
Haciyanli M, Lal G, Morita E, Duh QY, Kebebew E, Clark OH. Accuracy of preoperative localization studies and intraoperative parathyroid hormone assay in patients with primary hyperparathyroidism and double adenoma. J Am Coll Surg 2003; 197:739-746.
Hornung M, Jung EM, Stroszczynski C, Schlitt HJ, Agha A. Contrast-enhanced ultrasonography (CEUS) using early dynamic in microcirculation for localization of pathological parathyroid glands: first-line or complimentary diagnostic modality? Clin Hemorheol Microcirc 2011; 49:83-90.
Agha A, Hornung M, Stroszczynski C, Schlitt HJ, Jung EM. Highly efficient localization of pathological glands in primary hyperparathyroidism using contrast-enhanced ultrasonography (CEUS) in comparison with conventional ultrasonography. J Clin Endocrinol Metab 2013; 98:2019-2025.
Agha A, Hornung M, Schlitt HJ, Stroszczynski C, Jung EM. The role of contrast-enhanced ultrasonography (CEUS) in comparison with 99mtechnetium-sestamibi scintigraphy for localization diagnostic of primary hyperparathyroidism. Clin Hemorheol Microcirc 2014; 58: 515-520.
Ruda JM, Hollenbeak CS, Stack BC Jr. A systematic review of the diagnosis and treatment of primary hyperparathyroidism from 1995 to 2003. Otolaryngol Head Neck Surg 2005; 132:359-372.
Siperstein A, Berber E, Mackey R, Alghoul M, Wagner K, Milas M. Prospective evaluation of sestamibi scan, ultrasonography, and rapid PTH to predict the success of limited exploration for sporadic primary hyperparathyroidism. Surgery 2004; 136:872-880.
Yao M, Jamieson C, Blend R. Magnetic resonance imaging in preoperative localization of diseased parathyroid glands: a comparison with isotope scanning and ultrasonography. Can J Surg 1993; 36:241-244.
Krakauer M, Wieslander B, Myschetzky PS, et al. A prospective comparative study of parathyroid dual-phase scintigraphy, dual-isotope subtraction scintigraphy, 4D-TC, and ultrasonography in primary hyperparathyroidism. Clin Nucl Med 2016; 41:93-100.
Agha A, Hornung M, Rennert J, et al. Contrast-enhanced ultrasonography for localization of pathologic glands in patients with primary hyperparathyroidism. Surgery 2012; 151:580-586.
Mazzeo S, Caramella D, Marcocci C, et al. Contrast-enhanced color Doppler ultrasonography in suspected parathyroid lesions. Acta Radiol 2000; 41:412-416.
Uller W, Jung EM, Hornung M, et al. Evaluation of pathologic parathyroid glands in patients with primary hyperparathyroidism using conventional ultrasound and contrast-enhanced ultrasound. Clin Hemorheol Microcirc 2011; 48:95-103.